InsidersTradesSigma
Browse the detailed record of transactions filed by Gelder Mark S. MD, Directeur Médical. Director active across 1 companies, notably Onconova Therapeutics, Inc.. Cumulatively, 2 filings have been logged. Total volume traded: €17k. The latest transaction was filed on 28 September 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Mark S. Gelder is the Chief Medical Officer at Onconova Therapeutics, Inc. He is responsible for the company's medical and clinical strategies, ensuring innovation in treatment development. His medical expertise is essential for Onconova's mission.